American College of Allergy, Asthma, & Immunology (ACAAI) Annual Meeting

Virtual Event

Healix is proud to participate in clinical research at the 2020 American College of Allergy, Asthma, & Immunology (ACAAI) Annual Meeting. Visit our ePoster at this year’s virtual conference, available online beginning November 13, 2020, through August 2021.

(Abstract #P252) Real-World Evaluation of Immune Globulin Subcutaneous 16.5% in the Treatment of Primary Immunodeficiency: Six-Month Outcomes

Jeffrey W. Langford, MD, AE-C1; Richard F. Herrscher, MD, FACAAI2; Samantha A. Mehta, PharmD3; Jennifer L. Hames, MSPAS, PA-C1; Lucinda J. Van Anglen, PharmD3

1Langford Allergy, LLC, Macon, GA; 2AIR Care, Dallas, TX; 3Healix Infusion Therapy, LLC, Sugar Land, TX

Learn more about our outcomes research and how Healix can help you establish an office infusion center or outsource the management of an existing operation by contacting us today!


View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.